Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, ...
The test that was developed using an existing diagnostic procedure as its basis and has the potential to be applied in clinical trials that target the Epstein Barr Virus. A team of research scientists ...
Infectious mononucleosis (IM), also known as the kissing disease or “mono,” is typically caused by the Epstein-Barr virus (EBV). It is a clinical condition characterised by fever, lymphadenopathy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results